---
title: Developing survival prediction models in colorectal cancer using epigenome-wide
  DNA methylation data from whole blood
date: '2024-09-05'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39237753/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240906182443&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'While genome-wide association studies are valuable in identifying CRC
  survival predictors, the benefit of adding blood DNA methylation (blood-DNAm) to
  clinical features, including the TNM system, remains unclear. In a multi-site population-based
  patient cohort study of 2116 CRC patients with baseline blood-DNAm, we analyzed
  survival predictions using eXtreme Gradient Boosting with a 5-fold nested leave-sites-out
  cross-validation across four groups: traditional and comprehensive ...'
disable_comments: true
---
While genome-wide association studies are valuable in identifying CRC survival predictors, the benefit of adding blood DNA methylation (blood-DNAm) to clinical features, including the TNM system, remains unclear. In a multi-site population-based patient cohort study of 2116 CRC patients with baseline blood-DNAm, we analyzed survival predictions using eXtreme Gradient Boosting with a 5-fold nested leave-sites-out cross-validation across four groups: traditional and comprehensive ...